Wd. Ai et al., Yin Yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6, J VIROLOGY, 74(11), 2000, pp. 5198-5205
Human papillomavirus type 6 (HPV-6) is a low-risk HPV whose replication cyc
le, like that of all HPVs, is differentiation dependent. We have previously
shown that CCAAT displacement protein (CDP) binds the differentiation-indu
ced HPV-6 E1 promoter and negatively regulates its activity in undifferenti
ated cells (W. Ai, E. Toussaint. and A. Roman, J. Virol, 73:4220-1229, 1999
). Using electrophoretic mobility shift assays (EMSAs), we now report that
Yin Yang 1 (YY1), a multifunctional protein that can act as a transcription
al activator or repressor and that can also inhibit NPV replication in vitr
o, binds the HPV 6 E1 promoter. EMSAs, using subfragments of the promoter a
s competitors, showed that the YY1 binding site is located at the 5' end of
the E1 promoter. When a putative YY1 site was mutated, the ability of YY1
to bind was greatly decreased. The activity of the mutated E1 promoter, mon
itored with the reporter gene luciferase, was threefold greater than that o
f the wild-type promoter, suggesting that YY1 negatively regulates HPV-6 E1
promoter activity. Nuclear extracts from differentiated keratinocytes show
ed decreased binding of YY1 to the wild-type promoter. Consistent with this
, in differentiated keratinocytes, the activity of the transfected lucifera
se gene transcribed from the mutated promoter was comparable to that of the
wild-type promoter; both promoters were up-regulated in differentiated ker
atinocytes compared to undifferentiated cells. These data suggest that YY1
functions in undifferentiated keratinocytes but not in differentiated kerat
inocytes. Both the wild-type and mutated promoters could be negatively regu
lated by overexpression of a plasmid encoding CDP. Thus, both YY1 and CDP a
ppear to be negative regulators of the differentiation-induced HPV-6 E1 pro
moter and thereby the HPV life cycle. In contrast, only binding of CDP was
detected using the E1 promoter of the high-risk HPV-31.